{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:46:18Z","timestamp":1772815578378,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.jaad.2006.01.024","type":"journal-article","created":{"date-parts":[[2006,6,16]],"date-time":"2006-06-16T08:06:08Z","timestamp":1150445168000},"page":"163-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab"],"prefix":"10.1016","volume":"55","author":[{"given":"Noah","family":"Scheinfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.01.024_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2230.2004.01582.x","article-title":"Seronegative arthritis associated with the follicular occlusion triad","volume":"29","author":"Thein","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.jaad.2006.01.024_bib2","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.jaad.2004.09.006","article-title":"Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab","volume":"52","author":"Iqbal","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.01.024_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/120347540400800202","article-title":"A review of the use of infliximab to manage cutaneous dermatoses","volume":"8","author":"Gupta","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2006.01.024_bib4","first-page":"22","article-title":"TNF Inhibitor Puts the Brakes On Refractory Hidradenitis","volume":"36","author":"Walsh","year":"2005","journal-title":"Skin & Allergy News"},{"key":"10.1016\/j.jaad.2006.01.024_bib5","unstructured":"www.pubmed.gov search term \u201cadalimumab.\u201d Accessed November 12, 2005."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:02:38Z","timestamp":1759269758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0190962206000545"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.01.024","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}